AirStrip Technologies has received CE mark approval to market its mobile patient monitoring applications in the European Community as well as other international territories outside Europe, company officials announced on 3 January 2012.
Applications currently available include AirStrip OB, AirStrip Cardiology and AirStrip Patient Monitoring, currently approved in the US market. The applications give clinicians anytime, anywhere access to vital live and historical patient data including waveforms, ECGs and other information, right on their smartphone or tablet.
“This is a significant milestone that indicates our FDA-cleared solutions also meet the quality and safety standards required by the international healthcare marketplace,” said Alan Portela, AirStrip Technologies CEO. “We have seen an incredible level of interest in bringing our applications to Europe and other territories, and we can now aggressively move forward with our expansion plans.”
AirStrip announced recently a partnership with Qualcomm Life to develop and execute a home health monitoring initiative that integrates AirStrip solutions into the Qualcomm 2net Platform. The initial focus will be on helping curb hospital readmission rates for congestive heart failure patients.